{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:07:08Z","timestamp":1793614028560,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier","isbn-type":[{"value":"9780443295485","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-14\\u20131-0425"],"award-info":[{"award-number":["W81XWH-14\\u20131-0425"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001558","name":"Concern Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA276517\\u201301A1"],"award-info":[{"award-number":["R01 CA276517\\u201301A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.vh.2025.01.001","type":"book-chapter","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:08:24Z","timestamp":1737734904000},"page":"241-272","source":"Crossref","is-referenced-by-count":2,"title":["B lymphoproliferative diseases: Effective treatment, inhibited progression, and potential cures through isoform-specific targeting of the prolactin receptor"],"prefix":"10.1016","member":"78","reference":[{"issue":"10","key":"10.1016\/bs.vh.2025.01.001_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1134\/S0006297919100092","article-title":"Prolactin signaling pathways determining its direct effects on kidneys in the cholestasis of pregnancy model","volume":"84","author":"Abramicheva","year":"2019","journal-title":"Biochemistry. Biokhimiia"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1134\/S0006297919040011","article-title":"Prolactin receptor isoforms as the basis of tissue-specific action of prolactin in the norm and pathology","volume":"84","author":"Abramicheva","year":"2019","journal-title":"Biochemistry. Biokhimiia"},{"key":"10.1016\/bs.vh.2025.01.001_bib3","first-page":"6630715","article-title":"Prolactin increases the frequency of follicular T helper cells with enhanced IL21 secretion and OX40 expression in lupus-prone MRL\/lpr mice","author":"Alem\u00e1n-Garc\u00eda","year":"2021","journal-title":"Journal of Immunology Research"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1191\/096120398678920334","article-title":"Bromocriptine in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled study","volume":"7","author":"Alvarez-Nemegyei","year":"1998","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/bs.vh.2025.01.001_bib5","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1210\/en.2019-00234","article-title":"Widespread cell-specific prolactin receptor expression in multiple murine organs","volume":"160","author":"Aoki","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2025.01.001_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84645","article-title":"The prolactin receptor scaffolds Janus kinase 2 via co-structure formation with phosphoinositide-4,5-bisphosphate","volume":"12","author":"Araya-Secchi","year":"2023","journal-title":"Elife"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/clin.1993.1026","article-title":"Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro","volume":"66","author":"Athreya","year":"1993","journal-title":"Clinical Immunology and Immunopathology"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib8","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/art.11144","article-title":"Lymphoma subtypes in patients with rheumatoid arthritis: Increased proportion of diffuse large B cell lymphoma","volume":"48","author":"Baecklund","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/bs.vh.2025.01.001_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13385","article-title":"The prolactin receptor: A cross-species comparison of gene structure, transcriptional regulation, tissue-specificity, and genetic variation","author":"Banks","year":"2024","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/bs.vh.2025.01.001_bib10","article-title":"A cautionary tale: Alien prolactins may induce lesser, no, or opposite effects to homologous hormone!","author":"Barbee","year":"2022","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/bs.vh.2025.01.001_bib11","series-title":"Prolactin","first-page":"1","article-title":"Hypothalamic control of prolactin synthesis and secretion","author":"Ben-Jonathan","year":"2001"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2007-0017","article-title":"What can we learn from rodents about prolactin in humans?","volume":"29","author":"Ben-Jonathan","year":"2008","journal-title":"Endocrine Reviews"},{"issue":"7","key":"10.1016\/bs.vh.2025.01.001_bib13","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.4049\/jimmunol.146.7.2201","article-title":"Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue","volume":"146","author":"Berczi","year":"1991","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib14","doi-asserted-by":"crossref","first-page":"R198","DOI":"10.1186\/ar4388","article-title":"Cancer risk in childhood-onset systemic lupus","volume":"15","author":"Bernatsky","year":"2013","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: Effects of disease activity versus treatment","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib16","first-page":"343","article-title":"CD40-CD154 interaction in experimental and human disease (review)","volume":"3","author":"Biancone","year":"1999","journal-title":"International Journal of Molecular Medicine"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1076\/apab.109.2.180.4276","article-title":"Glycosylated rat prolactin: Isolation and structural characterization","volume":"109","author":"Bollengier","year":"2001","journal-title":"Archives of Physiology and Biochemistry"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2567.2010.03320.x","article-title":"The influence of regulatory T cells and diurnal hormone rhythms on T helper cell activity","volume":"131","author":"Bollinger","year":"2010","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4049\/jimmunol.163.2.576","article-title":"Immune system development and function in prolactin receptor-deficient mice","volume":"163","author":"Bouchard","year":"1999","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/bs.vh.2025.01.001_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13293-015-0037-7","article-title":"Sex differences in Sj\u00f6gren\u2019s syndrome: A comprehensive review of immune mechanisms","volume":"6","author":"Brandt","year":"2015","journal-title":"Biology of Sex Differences"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1095\/biolreprod.111.091918","article-title":"Reproductive experience alters prolactin receptor expression in mammary and hepatic tissues in female rats","volume":"85","author":"Bridges","year":"2011","journal-title":"Biology of Reproduction"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/er.2011-1040","article-title":"Molecular mechanisms of prolactin and its receptor","volume":"33","author":"Brooks","year":"2012","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.vh.2025.01.001_bib23","series-title":"Principles of endocrinology and hormone action","article-title":"Cytokine receptors","author":"Brooks","year":"2018"},{"key":"10.1016\/bs.vh.2025.01.001_bib24","doi-asserted-by":"crossref","first-page":"1017115","DOI":"10.3389\/fimmu.2022.1017115","article-title":"Prolactin promotes proliferation of germinal center B cells, formation of plasma cells, and elevated levels of IgG3 anti-dsDNA autoantibodies","volume":"13","author":"Carre\u00f3n-Talavera","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"11","key":"10.1016\/bs.vh.2025.01.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101195","article-title":"Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor","volume":"14","author":"Chen","year":"2021","journal-title":"Translational Oncology"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1210\/endo.139.2.5758","article-title":"Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone","volume":"139","author":"Chen","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2025.01.001_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18632\/genesandcancer.222","article-title":"Splice modulating oligomers as cancer therapeutics","volume":"13","author":"Chen","year":"2022","journal-title":"Genes and Cancer."},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib28","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1210\/endo.133.3.7689950","article-title":"The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis","volume":"133","author":"Clapp","year":"1993","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/bs.vh.2025.01.001_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tem.2009.03.001","article-title":"New mechanisms for PRLr action in breast cancer","volume":"20","author":"Clevenger","year":"2009","journal-title":"Trends in Endocrinology and Metabolism: TEM"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib30","first-page":"674","article-title":"The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes","volume":"8","author":"Clevenger","year":"1994","journal-title":"Molecular Endocrinology"},{"issue":"10","key":"10.1016\/bs.vh.2025.01.001_bib31","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac122","article-title":"Breast cancer and prolactin \u2013 new mechanisms and models","volume":"163","author":"Clevenger","year":"2022","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/bs.vh.2025.01.001_bib32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2009.05.002","article-title":"Natural and adaptive foxp3+ regulatory T cells: More of the same or a division of labor?","volume":"30","author":"Curotto de Lafaille","year":"2009","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/bs.vh.2025.01.001_bib33","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1210\/en.2006-1761","article-title":"Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a\/b signaling pathway","volume":"148","author":"Dagvadorj","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","article-title":"Prolactin and autoimmunity","volume":"8","author":"De Bellis","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/bs.vh.2025.01.001_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fendo.2019.00265","article-title":"Autoimmune disease in women: Endocrine transition and risk across the lifespan","volume":"10","author":"Desai","year":"2019","journal-title":"Frontiers in Endocrinology"},{"issue":"9","key":"10.1016\/bs.vh.2025.01.001_bib36","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1074\/jbc.M110.166603","article-title":"Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: Involvement of a novel phosphatase","volume":"286","author":"Devi","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2025.01.001_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1477-7827-7-87","article-title":"Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues","volume":"7","author":"Devi","year":"2009","journal-title":"Reproductive Biology and Endocrinology: RB&E"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib38","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1210\/endo-122-6-2508","article-title":"A human B-lymphoblastoid cell line produces prolactin","volume":"122","author":"DiMattia","year":"1988","journal-title":"Endocrinology"},{"issue":"44","key":"10.1016\/bs.vh.2025.01.001_bib39","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1038\/sj.onc.1208002","article-title":"Prolactin induces c-Myc expression and cell survival through activation of Src\/Akt pathway in lymphoid cells","volume":"23","author":"Dom\u00ednguez-C\u00e1ceres","year":"2004","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/bs.vh.2025.01.001_bib40","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1210\/en.2002-220515","article-title":"Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice","volume":"143","author":"Dugan","year":"2002","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1297-319X(03)00151-9","article-title":"Hyperprolactinemia in Sjogren\u2019s syndrome: A patient subset or a disease manifestation?","volume":"71","author":"El Miedany","year":"2004","journal-title":"Joint, Bone, Spine: Revue du Rhumatisme"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib42","first-page":"374","article-title":"Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestations","volume":"23","author":"El-Garf","year":"1996","journal-title":"The Journal of Rheumatology"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/a-1126-4272","article-title":"Immunomodulating effects depend on prolactin levels in patients with hyperprolactinemia","volume":"52","author":"Ewerman","year":"2020","journal-title":"Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib44","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.3390\/ijerph20043257","article-title":"The involvement of prolactin in stress-related disorders","volume":"20","author":"Faron-G\u00f3recka","year":"2023","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3390\/cells10020316","article-title":"Prolactin rescues immature B cells from apoptosis-induced BCR-aggregation through STAT3, Bcl2a1a, Bcl2l2, and Birc5 in lupus-prone MRL\/lpr mice","volume":"10","author":"Flores-Fern\u00e1ndez","year":"2021","journal-title":"Cells"},{"key":"10.1016\/bs.vh.2025.01.001_bib46","doi-asserted-by":"crossref","first-page":"3219017","DOI":"10.1155\/2016\/3219017","article-title":"Prolactin rescues immature B-cells from apoptosis induced by B-cell receptor cross-linking","volume":"2016","author":"Flores-Fern\u00e1ndez","year":"2016","journal-title":"Journal of Immunology Research"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib47","first-page":"849","article-title":"Elevated prolactin levels in patients with rheumatoid arthritis: Association with disease activity and structural damage","volume":"28","author":"Fojt\u00edkov\u00e1","year":"2010","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/bs.vh.2025.01.001_bib48","doi-asserted-by":"crossref","DOI":"10.1530\/EDM-14-0029","article-title":"Burkitt\u2019s lymphoma presenting with hypopituitarism: A case report and review of literature","volume":"2014","author":"Foo","year":"2014","journal-title":"Endocrinology, Diabetes & Metabolism Case Reports"},{"issue":"25","key":"10.1016\/bs.vh.2025.01.001_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/bs.vh.2025.01.001_bib50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/08880018.2020.1751754","article-title":"Very late recurrence of B-cell acute lymphoblastic leukemia masquerading as a pituitary tumor","volume":"37","author":"Fridlyand","year":"2020","journal-title":"Pediatric Hematology and Oncology"},{"issue":"10","key":"10.1016\/bs.vh.2025.01.001_bib51","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/bies.20468","article-title":"Prolactin in man: A tale of two promoters","volume":"28","author":"Gerlo","year":"2006","journal-title":"Bioessays: News and Reviews in Molecular, Cellular and Developmental Biology"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib52","doi-asserted-by":"crossref","first-page":"T101","DOI":"10.1530\/JOE-15-0213","article-title":"60 Years of neuroendocrinology: The hypothalamo-prolactin axis","volume":"226","author":"Grattan","year":"2015","journal-title":"The Journal of Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib53","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/endo-126-1-512","article-title":"Alterations in in situ prolactin secretory granule morphology and immunoactivity by thiols and divalent cations","volume":"126","author":"Greenan","year":"1990","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41523-021-00243-7","article-title":"The human intermediate prolactin receptor is a mammary proto-oncogene","volume":"7","author":"Grible","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.celrep.2016.08.076","article-title":"Truncating prolactin receptor mutations promote tumor growth in murine estrogen receptor-alpha mammary carcinomas","volume":"17","author":"Griffith","year":"2016","journal-title":"Cell Reports"},{"issue":"48","key":"10.1016\/bs.vh.2025.01.001_bib56","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1055\/s-2008-1065232","article-title":"Hyperprolactinemia in malignant lymphomas","volume":"115","author":"Grobe","year":"1990","journal-title":"Deutsche Medizinische Wochenschrift (1946)"},{"issue":"31","key":"10.1016\/bs.vh.2025.01.001_bib57","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1073\/pnas.1404267111","article-title":"Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice","volume":"111","author":"Hartwell","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2025.01.001_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ygcen.2014.11.004","article-title":"Autocrine\/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: An overview","volume":"220","author":"Harvey","year":"2015","journal-title":"General and Comparative Endocrinology"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib59","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1042\/BJ20141243","article-title":"Intrinsically disordered cytoplasmic domains of two cytokine receptors mediate conserved interactions with membranes","volume":"468","author":"Haxholm","year":"2015","journal-title":"Biochemical Journal"},{"issue":"10","key":"10.1016\/bs.vh.2025.01.001_bib60","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/BF03348932","article-title":"Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance","volume":"16","author":"Hoffmann","year":"1993","journal-title":"Journal of Endocrinological Investigation"},{"issue":"23","key":"10.1016\/bs.vh.2025.01.001_bib61","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","article-title":"Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene","volume":"16","author":"Horseman","year":"1997","journal-title":"The EMBO Journal"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2014.12.031","article-title":"Blockade of estrogen-stimulated proliferation by a constitutively-active prolactin receptor having lower expression in invasive ductal carcinoma","volume":"358","author":"Huang","year":"2015","journal-title":"Cancer Letters"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10911-008-9072-x","article-title":"Paradigm-shifters: Phosphorylated prolactin and short prolactin receptors","volume":"13","author":"Huang","year":"2008","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/pros.21036","article-title":"Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity","volume":"70","author":"Huang","year":"2010","journal-title":"The Prostate"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib65","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.41632","article-title":"Prevalence of systemic lupus erythematosus in the United States: Estimates from a meta-analysis of the centers for disease control and prevention national lupus registries","volume":"73","author":"Izmirly","year":"2021","journal-title":"Arthritis & Rheumatology"},{"issue":"2\u20133","key":"10.1016\/bs.vh.2025.01.001_bib66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12026-014-8577-1","article-title":"Risk factors of systemic lupus erythematosus flares during pregnancy","volume":"60","author":"Jara","year":"2014","journal-title":"Immunologic Research"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib67","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12026-016-8891-x","article-title":"Prolactin has a pathogenic role in systemic lupus erythematosus","volume":"65","author":"Jara","year":"2017","journal-title":"Immunologic Research"},{"issue":"10","key":"10.1016\/bs.vh.2025.01.001_bib68","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1191\/096120301717164994","article-title":"Prolactin in human systemic lupus erythematosus","volume":"10","author":"Jara","year":"2001","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/bs.vh.2025.01.001_bib69","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/1440-1681.13818","article-title":"Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway","volume":"50","author":"Jiang","year":"2023","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"45","key":"10.1016\/bs.vh.2025.01.001_bib70","doi-asserted-by":"crossref","first-page":"33118","DOI":"10.1074\/jbc.M704364200","article-title":"Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL","volume":"282","author":"Jomain","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2025.01.001_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.949396","article-title":"Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness","volume":"13","author":"Kavarthapu","year":"2022","journal-title":"Frontiers in Endocrinology"},{"issue":"8","key":"10.1016\/bs.vh.2025.01.001_bib72","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002923","article-title":"Pineal diffuse large B-cell lymphoma concomitant with pituitary prolactinoma: Possible correlation between 2 distinguished pathologies: A case report","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine"},{"issue":"27","key":"10.1016\/bs.vh.2025.01.001_bib73","doi-asserted-by":"crossref","first-page":"24760","DOI":"10.1074\/jbc.M011786200","article-title":"Identification and characterization of the prolactin-binding protein in human serum and milk","volume":"276","author":"Kline","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1677\/joe.0.1780265","article-title":"Prolactin regulation of Bcl-2 family members: Increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells","volume":"178","author":"Kochendoerfer","year":"2003","journal-title":"The Journal of Endocrinology"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib75","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/17474086.2016.1180972","article-title":"B cells gone rogue: The intersection of diffuse large B cell lymphoma and autoimmune disease","volume":"9","author":"Koff","year":"2016","journal-title":"Expert Review of Hematology"},{"key":"10.1016\/bs.vh.2025.01.001_bib76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0065-3233(04)68005-3","article-title":"The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors","volume":"68","author":"Kossiakoff","year":"2004","journal-title":"Advances in Protein Chemistry"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib77","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.vh.2025.01.001_bib78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/978-0-387-89520-8_2","article-title":"Therapeutic interventions targeting CD40L (CD154) and CD40: The opportunities and challenges","volume":"647","author":"Law","year":"2009","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1095\/biolreprod.111.095927","article-title":"Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function","volume":"86","author":"Le","year":"2012","journal-title":"Biology of Reproduction"},{"key":"10.1016\/bs.vh.2025.01.001_bib80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2172-13-11","article-title":"Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1 B cells after prolactin treatment","volume":"13","author":"Ledesma-Soto","year":"2012","journal-title":"BMC Immunology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1016-8478(23)15013-8","article-title":"Expression of p21WAF1 is dependent on the activation of ERK during vitamin E-succinate-induced monocytic differentiation","volume":"13","author":"Lee","year":"2002","journal-title":"Molecules and Cells"},{"issue":"15","key":"10.1016\/bs.vh.2025.01.001_bib82","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1074\/jbc.274.15.10024","article-title":"Constitutive activation of the prolactin receptor results in the induction of growth factor-independent proliferation and constitutive activation of signaling molecules","volume":"274","author":"Lee","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/JME-11-0040","article-title":"Prolactin down-regulates CD4+CD25hiCD127low\/-regulatory T cell function in humans","volume":"48","author":"Legorreta-Haquet","year":"2012","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/bs.vh.2025.01.001_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/287469","article-title":"Prolactin levels correlate with abnormal B cell maturation in MRL and MRL\/lpr mouse models of systemic lupus erythematosus-like disease","volume":"2013","author":"Legorreta-Haquet","year":"2013","journal-title":"Clinical & Developmental Immunology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib85","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/endo-116-1-359","article-title":"Glycosylated human prolactin","volume":"116","author":"Lewis","year":"1985","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib86","first-page":"31","article-title":"Regulation of p21WAF1\/CIP1 expression through mitogen-activated protein kinase signaling pathway","volume":"56","author":"Liu","year":"1996","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib87","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12020-019-01896-y","article-title":"Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets","volume":"64","author":"Liu","year":"2019","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib88","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1210\/endo-116-4-1399","article-title":"In vitro conditions modify immunoassayability of bovine pituitary prolactin and growth hormone: Insights into their secretory granule storage forms","volume":"116","author":"Lorenson","year":"1985","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib89","doi-asserted-by":"crossref","first-page":"bpy014","DOI":"10.1093\/biomethods\/bpy014","article-title":"Enzyme-linked oligonucleotide hybridization assay for direct oligo measurement in blood","volume":"4","author":"Lorenson","year":"2019","journal-title":"Biology Methods and Protocols"},{"issue":"5","key":"10.1016\/bs.vh.2025.01.001_bib90","doi-asserted-by":"crossref","first-page":"E585","DOI":"10.1152\/ajpendo.00480.2011","article-title":"A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: The complex is not the prolactin receptor","volume":"302","author":"Lorenson","year":"2012","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib91","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/protein\/5.6.559","article-title":"Analysis of disulphide bridge function in recombinant bovine prolactin using site-specific mutagenesis and renaturation under mild alkaline conditions: A crucial role for the central disulphide bridge in the mitogenic activity of the hormone","volume":"5","author":"Luck","year":"1992","journal-title":"Protein Engineering"},{"issue":"40","key":"10.1016\/bs.vh.2025.01.001_bib92","first-page":"1","article-title":"Anterior pituitary gland and lymphoid tissue growth","volume":"28","author":"Lundin","year":"1958","journal-title":"Acta Endocrinologica. Supplementum"},{"issue":"5","key":"10.1016\/bs.vh.2025.01.001_bib93","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/me.2013-1349","article-title":"Minireview: Extrapituitary prolactin: An update on the distribution, regulation, and functions","volume":"28","author":"Marano","year":"2014","journal-title":"Molecular Endocrinology (Baltimore, Md.)"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<124::AID-IJC22>3.0.CO;2-U","article-title":"Expression of prolactin and prolactin receptors by non-Hodgkin\u2019s lymphoma cells","volume":"85","author":"Matera","year":"2000","journal-title":"International Journal of Cancer"},{"issue":"11","key":"10.1016\/bs.vh.2025.01.001_bib95","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.4049\/jimmunol.147.11.3780","article-title":"Prolactin influences autoimmune disease activity in the female B\/W mouse","volume":"147","author":"McMurray","year":"1991","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"issue":"16","key":"10.1016\/bs.vh.2025.01.001_bib96","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1158\/0008-5472.CAN-04-1019","article-title":"Human prolactin receptor variants in breast cancer: Low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma","volume":"64","author":"Meng","year":"2004","journal-title":"Cancer Research"},{"issue":"9","key":"10.1016\/bs.vh.2025.01.001_bib97","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.21873\/anticanres.14526","article-title":"Phase I study of LFA102 in patients with advanced breast cancer or castration-resistant prostate cancer","volume":"40","author":"Minami","year":"2020","journal-title":"Anticancer Research"},{"issue":"5","key":"10.1016\/bs.vh.2025.01.001_bib98","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.1986.tb03608.x","article-title":"Asymptomatic hyperprolactinaemia and prolactinoma in the general population\u2014Mass screening by paired assays of serum prolactin","volume":"25","author":"Miyai","year":"1986","journal-title":"Clinical Endocrinology"},{"issue":"10","key":"10.1016\/bs.vh.2025.01.001_bib99","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1191\/096120301717164895","article-title":"Prolactin production by immune cells","volume":"10","author":"Montgomery","year":"2001","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib100","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1210\/endo.139.2.5913","article-title":"Prolactin stimulates phosphorylation of the human T-cell antigen receptor complex and ZAP-70 tyrosine kinase: A potential mechanism for its immunomodulation","volume":"139","author":"Montgomery","year":"1998","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib101","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/0006-291X(87)91020-5","article-title":"Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity","volume":"145","author":"Montgomery","year":"1987","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib102","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2249.1993.tb07966.x","article-title":"Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro","volume":"93","author":"Morkawa","year":"1993","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib103","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib104","first-page":"139","article-title":"The effect of hypophysectomy, and x-irradiation on lymphoid organs and on the induction of lymphoid tumors in C57BL mice","volume":"16","author":"Nagareda","year":"1955","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib105","first-page":"351","article-title":"Regulation of immunity in rats by lactogenic and growth hormones","volume":"102","author":"Nagy","year":"1983","journal-title":"Acta Endocrinologica"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib106","first-page":"530","article-title":"Immunodeficiency in hypophysectomized rats","volume":"89","author":"Nagy","year":"1978","journal-title":"Acta Endocrinologica"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib107","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0303-7207(89)90130-5","article-title":"Production and secretion of the 21\u201323.5 kDa prolactin-like molecules","volume":"61","author":"Oetting","year":"1989","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib108","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0021-9258(17)35989-6","article-title":"Phosphorylation of prolactin","volume":"261","author":"Oetting","year":"1986","journal-title":"The Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/bs.vh.2025.01.001_bib109","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.autrev.2006.10.005","article-title":"Hyperprolactinemia and autoimmune diseases","volume":"6","author":"Orbach","year":"2007","journal-title":"Autoimmunity Reviews"},{"issue":"4","key":"10.1016\/bs.vh.2025.01.001_bib110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1023\/A:1026395229025","article-title":"Mammary gland development in prolactin receptor knockout mice","volume":"2","author":"Ormandy","year":"1997","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"issue":"5 Pt 1","key":"10.1016\/bs.vh.2025.01.001_bib111","first-page":"G807","article-title":"Visualization of gene expression of short and long forms of prolactin receptor in rat digestive tissues","volume":"266","author":"Ouhtit","year":"1994","journal-title":"American Journal of Physiology"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib112","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1095\/biolreprod49.3.528","article-title":"Visualization of gene expression of short and long forms of prolactin receptor in rat reproductive tissues","volume":"49","author":"Ouhtit","year":"1993","journal-title":"Biology of Reproduction"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib113","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.177.3.1401","article-title":"Cutting edge: Lupus susceptibility interval Sle3\/5 confers responsiveness to prolactin in C57BL\/6 mice","volume":"177","author":"Peeva","year":"2006","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib114","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI200316530","article-title":"Prolactin modulates the naive B cell repertoire","volume":"111","author":"Peeva","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2005.05.014","article-title":"Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes","volume":"101","author":"Peeva","year":"2005","journal-title":"Immunology Letters"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib116","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0303-7207(97)00063-4","article-title":"The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor","volume":"129","author":"Pezet","year":"1997","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"8","key":"10.1016\/bs.vh.2025.01.001_bib117","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nature Reviews. Nephrology"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib118","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1210\/en.2009-0964","article-title":"Prolactin exerts a prosurvival effect on human spermatozoa via mechanisms that involve the stimulation of Akt phosphorylation and suppression of caspase activation and capacitation","volume":"151","author":"Pujianto","year":"2010","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/bs.vh.2025.01.001_bib119","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1096\/fba.2022-00004","article-title":"Multiple cell types in the oviduct express the prolactin receptor","volume":"4","author":"Radecki","year":"2022","journal-title":"FASEB BioAdvances"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1677\/jme.0.0220285","article-title":"The human prolactin gene upstream promoter is regulated in lymphoid cells by activators of T-cells and by cAMP","volume":"22","author":"Reem","year":"1999","journal-title":"Journal of Molecular Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib121","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0165-5728(00)00303-9","article-title":"Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function","volume":"109","author":"Richards","year":"2000","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/bs.vh.2025.01.001_bib122","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fimmu.2018.00611","article-title":"Gender bias in human systemic lupus erythematosus: A problem of steroid receptor action?","volume":"9","author":"Rider","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"10.1016\/bs.vh.2025.01.001_bib123","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.187.9.1517","article-title":"Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice","volume":"187","author":"Riminton","year":"1998","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/bs.vh.2025.01.001_bib124","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1546-0096-7-17","article-title":"Galactorrhea associated with juvenile systemic lupus erythematosus: A review of the role of prolactin","volume":"7","author":"Ronis","year":"2009","journal-title":"Pediatric Rheumatology Online Journal"},{"issue":"9","key":"10.1016\/bs.vh.2025.01.001_bib125","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/s41375-019-0508-7","article-title":"Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: A technical feasibility study by EuroClonality-NGS","volume":"33","author":"Scheijen","year":"2019","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U. K"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JME-14-0212","article-title":"Comparative genomics reveals tissue-specific regulation of prolactin receptor gene expression","volume":"54","author":"Schennink","year":"2015","journal-title":"Journal of Molecular Endocrinology"},{"issue":"12","key":"10.1016\/bs.vh.2025.01.001_bib127","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1210\/en.2003-0826","article-title":"Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL","volume":"144","author":"Schroeder","year":"2003","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/bs.vh.2025.01.001_bib128","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/mend.14.10.0536","article-title":"Prolactin stimulates activation of c-jun N-terminal kinase (JNK)","volume":"14","author":"Schwertfeger","year":"2000","journal-title":"Molecular Endocrinology (Baltimore, Md.)"},{"key":"10.1016\/bs.vh.2025.01.001_bib129","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007461","article-title":"Acute lymphoblastic leukaemia presenting with galactorrhoea","volume":"2013","author":"See","year":"2013","journal-title":"BMJ Case Reports"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: A meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib131","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12969-023-00915-7","article-title":"Circulating prolactin level in Juvenile Systemic Lupus Erythematosus and its correlation with disease activity: A case control study","volume":"21","author":"Soliman","year":"2023","journal-title":"Pediatric Rheumatology Online Journal"},{"issue":"7","key":"10.1016\/bs.vh.2025.01.001_bib132","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/0008-5472.CAN-16-1454","article-title":"Prolactin receptor-mediated internalization of imaging agents detects epithelial ovarian cancer with enhanced sensitivity and specificity","volume":"77","author":"Sundaram","year":"2017","journal-title":"Cancer Research"},{"issue":"12","key":"10.1016\/bs.vh.2025.01.001_bib133","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1172\/JCI72415","article-title":"Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression","volume":"124","author":"Sungalee","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"issue":"7","key":"10.1016\/bs.vh.2025.01.001_bib134","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ni.3160","article-title":"Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia","volume":"16","author":"Swaminathan","year":"2015","journal-title":"Nature Immunology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s42003-023-04667-8","article-title":"Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms","volume":"6","author":"Taghi Khani","year":"2023","journal-title":"Communications Biology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib136","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2011.06.014","article-title":"Prolactin increases survival and migration of ovarian cancer cells: Importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists","volume":"310","author":"Tan","year":"2011","journal-title":"Cancer Letters"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib137","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/bi7013882","article-title":"S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain","volume":"47","author":"Tan","year":"2008","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/bs.vh.2025.01.001_bib138","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4077\/CJP.2013.BAB139","article-title":"Histone trimethylation of the p53 gene by expression of a constitutively active prolactin receptor in prostate cancer cells","volume":"56","author":"Tan","year":"2013","journal-title":"Chinese Journal of Physiology"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib139","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1677\/JME-09-0101","article-title":"Short form 1b human prolactin receptor down-regulates expression of the long form","volume":"44","author":"Tan","year":"2010","journal-title":"Journal of Molecular Endocrinology"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib140","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: A comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer Journal"},{"issue":"2","key":"10.1016\/bs.vh.2025.01.001_bib141","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002640","article-title":"Association between prolactin and incidence of cardiovascular risk factors in the framingham heart study","volume":"5","author":"Therkelsen","year":"2016","journal-title":"Journal of the American Heart Association"},{"issue":"12","key":"10.1016\/bs.vh.2025.01.001_bib142","doi-asserted-by":"crossref","first-page":"bvac161","DOI":"10.1210\/jendso\/bvac161","article-title":"Pituitary infiltration by lymphoma","volume":"6","author":"Tovar-M\u00e9ndez","year":"2022","journal-title":"Journal of the Endocrine Society"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib143","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1677\/jme.0.0300031","article-title":"Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein","volume":"30","author":"Trott","year":"2003","journal-title":"Journal of Molecular Endocrinology"},{"issue":"6","key":"10.1016\/bs.vh.2025.01.001_bib144","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2008.10.035","article-title":"Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity","volume":"135","author":"Tsai","year":"2008","journal-title":"Cell"},{"issue":"15","key":"10.1016\/bs.vh.2025.01.001_bib145","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-13-0665","article-title":"A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development","volume":"73","author":"Tworoger","year":"2013","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-2795(199709)48:1<45::AID-MRD6>3.0.CO;2-P","article-title":"Prolactin receptor expression in the developing mouse embryo","volume":"48","author":"Tzeng","year":"1997","journal-title":"Molecular Reproduction and Development"},{"issue":"10","key":"10.1016\/bs.vh.2025.01.001_bib147","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1210\/en.2006-0348","article-title":"S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells","volume":"147","author":"Ueda","year":"2006","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib148","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1677\/erc.1.01076","article-title":"A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone","volume":"13","author":"Ueda","year":"2006","journal-title":"Endocrine-Related Cancer"},{"issue":"Pt 3","key":"10.1016\/bs.vh.2025.01.001_bib149","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1042\/bj20030859","article-title":"Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation","volume":"377","author":"Van Coppenolle","year":"2004","journal-title":"The Biochemical Journal"},{"key":"10.1016\/bs.vh.2025.01.001_bib150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"Van Kooten","year":"2000","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/bs.vh.2025.01.001_bib151","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1741-7015-7-12","article-title":"Sex differences in rheumatoid arthritis: More than meets the eye","volume":"7","author":"van Vollenhoven","year":"2009","journal-title":"BMC Medicine"},{"issue":"3","key":"10.1016\/bs.vh.2025.01.001_bib152","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/096120301666625458","article-title":"Treatment of systemic lupus erythematosus with bromocriptine","volume":"10","author":"Walker","year":"2001","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib153","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096120339500400102","article-title":"Prolactin: A stimulator of disease activity in systemic lupus erythematosus","volume":"4","author":"Walker","year":"1995","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/bs.vh.2025.01.001_bib154","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1073\/pnas.92.8.3278","article-title":"Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes","volume":"92","author":"Walker","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12016-009-8192-4","article-title":"The unexplained female predominance of systemic lupus erythematosus: Clues from genetic and cytokine studies","volume":"40","author":"Weckerle","year":"2011","journal-title":"Clinical Reviews in Allergy & Immunology"},{"issue":"8","key":"10.1016\/bs.vh.2025.01.001_bib156","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/08916934.2011.577128","article-title":"AID dysregulation in lupus-prone MRL\/Fas(lpr\/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc\/IgH loci translocations: Modulation by HoxC4","volume":"44","author":"White","year":"2011","journal-title":"Autoimmunity"},{"issue":"24","key":"10.1016\/bs.vh.2025.01.001_bib157","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1021\/bi034217s","article-title":"Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways","volume":"42","author":"Wu","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/bs.vh.2025.01.001_bib158","doi-asserted-by":"crossref","unstructured":"Wu, W., Deng, C., Brockman, J. L., Schuler, L. A., & Walker, A. M. (2021). Pseudophosphorylated prolactin: Enhanced transcription and message stabilization. https:\/\/doi.org\/10.5772\/intechopen.101256. https:\/\/www.intechopen.com\/online-first\/superior-stimulation-of-casein-mrna-accumulation-by-pseudophosphorylated-prolactin-enhanced-transcri.","DOI":"10.5772\/intechopen.101256"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib159","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1210\/endo.137.1.8536634","article-title":"Expression and localization of prolactin messenger ribonucleic acid in the human immune system","volume":"137","author":"Wu","year":"1996","journal-title":"Endocrinology"},{"issue":"16","key":"10.1016\/bs.vh.2025.01.001_bib160","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1158\/0008-5472.CAN-04-3350","article-title":"S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells","volume":"65","author":"Wu","year":"2005","journal-title":"Cancer Research"},{"issue":"16","key":"10.1016\/bs.vh.2025.01.001_bib161","first-page":"6098","article-title":"A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice","volume":"61","author":"Xu","year":"2001","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/bs.vh.2025.01.001_bib162","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0961203315622276","article-title":"Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus","volume":"25","author":"Yang","year":"2016","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/bs.vh.2025.01.001_bib163","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2015.06.010","article-title":"Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer","volume":"366","author":"Yonezawa","year":"2015","journal-title":"Cancer Letters"},{"issue":"8","key":"10.1016\/bs.vh.2025.01.001_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041644","article-title":"Aberrant CD40-induced NF-\u03baB activation in human lupus B lymphocytes","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/bs.vh.2025.01.001_bib165","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: A meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Archives of Internal Medicine"}],"container-title":["Vitamins and Hormones","Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672925000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:40:36Z","timestamp":1762231236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672925000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443295485"],"references-count":165,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2025.01.001","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}